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Abstract. Shortly after extracorporeal shock wave lithotripsy (ESWL) was 
introduced as a promising new treatment modality for gallstone disease, 
a randomized controlled study was performed to assess the cost-effective- 
ness of ESWL compared to open cholecystectomy, the gold standard. 
During the performance of this study it was found that during a 3-year 
intake period only 8.3% (37 of 448) of the patients could be entered into 
the trial. Three factors were identified that hampered patient accrual: (1) 
restricted eligibility for ESWL (and thus for the study), which could not 
have been predicted on the data provided in the literature; (2) the 
introduction of laparoscopic cholecystectomy; and (3) strong patient 
preference, inhibiting randomization. All three mechanisms could not 
have been predicted during the design phase of the study. It is concluded 
that it is not always feasible to conduct a randomized study in surgery due 
to unforeseen circumstances. Entering patients into surgical trials is 
difficult in quickly evolving fields of surgery, such as the management of 
gallstone disease. Acquiring informed consent is also difficult when 
treatment characteristics are divergent. A randomized controlled study 
on the effects of laparoscopic cholecystectomy will therefore probably 
never be performed. 
Gallstone disease is an important clinical problem in Western 
countries and traditionally considered a surgical problem. It is 
generally agreed that open cholecystectomy is the standard ther- 
apy for symptomatic gallstones [1, 2]. Still, much effort is put into 
the development of alternative, preferably noninvasive, treatment 
modalities for gallstone disease [3]. One of these recently devel- 
oped, noninvasive, treatment modalities is extracorporeal shock 
wave lithotripsy (ESWL). The initial results of ESWL to treat 
gallbladder stones were promising [3-5]. 
Because of the possible positive clinical and economic onse- 
quences of ESWL, we started a study on the effects of this new 
technique and its cost-effectiveness [6]. We chose a randomized 
controlled esign because randomized studies are considered to 
provide the most reliable information for proper evaluation of 
new techniques [7-14]. Moreover, in this way discussions could be 
avoided, similar to the ones that developed after the general 
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adoption of ESWL of kidney stones: This treatment modality 
almost completely displaced open surgery without a randomized 
study ever being performed [15-17]. 
During the performance of our study, several problems were 
encountered in acquiring adequate patient accrual. In this paper 
we describe the difficulties we met in this area. 
Patients and Methods 
To ensure optimal patient accrual for our randomized study, a 
surgical outpatient clinic solely for gallstone patients was started. 
Over a 3-year intake period, 596 patients visited this outpatient 
clinic. 
All patients were analyzed according to protocol. A history was 
obtained and a physical examination performed for all patients. 
Using the Roma Working Group definition [18], patients were 
diagnosed as either symptomatic or asymptomatic. Asymptomatic 
patients were excluded from further analysis and did not receive 
therapy. With symptomatic patients the various therapeutic op- 
tions were discussed, and these patients underwent further anal- 
ysis: laboratory tests and radiologic examination. 
Laboratory tests consisted of liver function tests for screening 
on common bile duct stones. Radiologic examination comprised 
ultrasonography (US) and oral cholecystography (OCG). OCG 
was not performed if the patient refused ESWL as a therapeutic 
option or if a previous US examination already excluded the 
patient from ESWL (Table 1). 
At the end of analysis, all eligible patients were informed about 
the study and were asked to consent o be randomized. When 
informed consent was given, therapy was randomly assigned, and 
self-administered health questionnaires and interviews were un- 
dertaken at 0, 3, 6, 12, 18, and 24 months. If patients did not want 
to participate in the study, they received the therapy of their 
choice. 
The study protocol was approved by the Medical Ethics Corn- 
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Table 1. Selection criteria for entering the Rotterdam Gallstone Study 
(ESWL of gallstones versus open cholecystectomy). 
Inclusion criteria 
Symptomatic gallbladder stones (last biliary colic < 2 years ago) 
Visualization of the gallbladder on oral cholecystography 
Up to 10 stones on ultrasonography; noupper limit for stone 
diameter 
Diameter of the largest stone > 5 mm on ultrasonography 
Radiolucent s ones or small calcified rim (< 2 ram) on oral 
cholecystography 
Age 30-70 years 
Informed consent 
Exclusion criteria 
Acute biliary disease (cholecystitis, jaundice, cholangitis, pancreatitis, 
hepatitis, or concomitant bile duct stones) 
Elevated serum activity of liver enzymes (> two times the upper 
range of reference values) 
Aneurysms or cysts in the shock wave path 
Coagulopathy 
Pregnancy 
American Society of Anesthesiologists (ASA) III/IV ~ 
Not able to fulfill follow-up 
ESWL: extracorporeal shock wave lithotripsy. 
aASA III: severe systemic disease limiting activity but not incapaci- 
tating; ASA IV: incapacitating systemic disease. 
mittee of the University Hospital "Dijkzigt" and the Erasmus 
University. 
Results 
From April 1989 to April 1992, 596 (successively, 238, 179, and 
179 per year) patients visited the outpatient clinic. A total of 367 
patients (61,6%) were referred by their general practitioner, 141 
(23.7%) by specialists, and 88 (14.8%) visited on their own 
initiative. A group of 584 patients (98.0%) underwent US and 345 
(57.9%) OCG. 
There were 12 patients who discontinued analysis, and 96 
patients were not symptomatic (Table 2). Of 488 patients, poten- 
tially randomizable, 310 (63.5%) were excluded because they did 
not meet the entry criteria (Table 1). Another 141 patients 
(28.9%) were excluded because they denied random assignment 
of therapy. Hence 37 patients (18, 12, and 7 for each year, 
respectively) consented to enter the study, which is 6.2% of the 
total number of analyzed patients and 7.6% of the patients 
potentially randomizable. There were 18 patients randomized for 
cholecystectomy and 19 for ESWL. 
Discussion 
There is unanimous agreement that new treatment techniques 
should be introduced in a manner that allows proper evaluation 
[7]. Although randomized studies have specific problems, they are 
considered to provide the most reliable information for such 
evaluation [7-14, 19]. The mechanism of allocating patients to 
different reatment schemes by randomization is accepted almost 
without question ow [10]. 
New surgical techniques are considered more difficult to eval- 
uate than new drugs [16, 20]. In fact, most clinical research in 
surgery relies on comparison with historical or contemporary 
nonrandom controls [11]. One of the most striking examples of 
Table 2. Reasons for not entering the study. 
Excluded 
Parameter Total no. No. % Reason for exclusion 
Referred 596 12 2.0 Discontinuation f analysis 
584 96 16.1 Not symptomatic 
Symptomatic 488 86 14.4 Age 
402 224 37.6 Contraindications toESWL 
178 66 11.1 Preference for cholecystectomy 
112 75 12.6 Preference for ESWL 
Eligible 37 6.2 ~ 
ESWL: extracorporeal shock wave lithotripsy. 
aThis group comprised 7.6% of 488 potentially randomizable pa- 
tients. 
this phenomenon is ESWL of renal and ureteric calculi, which 
completely displaced open surgery [15]. This development conse- 
quently led to much discussion, as no randomized study was ever 
performed [16, 17]. When ESWL was introduced for the disinte- 
gration of gallbladder stones, it was therefore suggested that the 
proper assessment of the role of ESWL should be dealt with in the 
context of a randomized trial [3]. 
During the performance of our study, only a few patients could 
be randomized. It should be noted here that despite this poor 
patient entry it was decided to continue the study because (1) 
interim analysis showed some interesting points; (2) five other 
hospitals decided to participate in the study; and (3) a large 
number of nonrandomized patients were entered into the study. 
However, because this point is not the subject of this manuscript 
it is not discussed here. 
Poor patient entry was due to three mechanisms that could not 
have been predicted when the study was designed: (1) Contrary to 
the data in the literature, eligibility for ESWL was found to be 
limited. (2) Yet another alternative treatment of gallbladder 
stones was introduced uring the performance of our study. (3) 
Strong patient preference for one of the two treatment arms was 
encountered that inhibited randomization. 
Restricted Eligibility for ESWL 
Partial applicability had already been reported by Sackmann and 
coworkers [4], but this point was not considered a major obstacle 
for our study, as we had reasons to assume that our eligibility rate 
would be higher than that reported by the Munich group, because 
our entry criteria (Table 1) were much wider than those of the 
Munich group, especially with regard to the maximum number of 
stones (10 versus 3), and another esearch group had reported a
randomization rate of 57.1% in a trial comparable to ours [21]. 
Moreover, even at Sackmann et al.'s eligibility rate of 28%, 
accrual of 160 patients--estimated o be necessary to detect any 
clinically relevant differences in the two treatment options--was 
considered to be easily achieved within 3 years at our referral rate 
of approximately 200 patients per year. 
Introduction of Another Alternative Treatment 
Shortly after our study was started, a new variant of classic 
cholecystectomy was introduced: laparoscopic holecystectomy 
[22, 23]. Compared to the "open" technique, laparoscopic chole- 
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Table 3. Baseline characteristics between cholecystectomy and extra- 
corporeal shock wave lithotripsy. 
Characteristic Cholecystectomy ESWL 
Outpatient procedure - + 
General anesthesia + - 
Curative + - 
Probability on stone - + 
recurrence 
Biliary colic after initial 0% 35% 
therapy 
Morbidity 10-30% < 5% 
Mortality 0.1-0.3% 0% 
Adjuvant reatment a required - + 
ESWL: extracorporeal shock wave lithotripsy. 
aOrally administered bile acids. 
cystectomy is reported to have several advantages. It is accompa- 
nied by less morbidity and mortality and consequently by a 
reduction in duration of hospitalization, the time to return to full 
activity, and the need for analgesic drugs. Also for cosmetic 
reasons, laparoscopic cholecystectomy is more attractive. Laparo- 
scopic cholecystectomy is now considered the gold standard [24] 
even though this technique has not been studied in the context of 
a randomized trial. 
Strong Patient Preference 
Many mechanisms can lead to strong patient preference. Two 
mechanisms limited accrual in our case: adherence to new tech- 
nologies and the divergent character of the two treatment arms. 
The lay press probably reinforced these two mechanisms. 
Adherence to New Technologies. Emotional adherence to a new 
technology is considered a major obstacle for randomization, and 
it may become insurmountable if it has become known to the 
general public [13]. We encountered this phenomenon twice: at 
the beginning of the study when patients pecifically chose ESWL, 
and at a later stage of the trial when patients pecifically opted for 
laparoscopic cholecystectomy. 
Divergent Character of the Two Treatment Arms. Strong patient 
preference also occurs when the treatment modalities tudied are 
divergent [25, 26]. ESWL and cholecystectomy have indeed 
different characteristics (Table 3); and because the outcomes of 
these characteristics were so clear to many patients they specifi- 
cally opted for a certain treatment modality and simply rejected 
random assignment. 
It has been recognized that comparing treatment regimens with 
divergent characteristics i  difficult [27]: Only 2% of eligible 
patients are recruited in breast cancer trials in the United States 
[28]; and in a trial comparing mastectomy and conservation 
surgery in Great Britain fewer than half of the eligible patients 
could be recruited [29]. Recently, some of the large trials com- 
paring percutaneous transluminal coronary angioplasty (PTCA) 
and coronary artery bypass graft (CBAG) have also had to stop 
patient intake without having recruited the desired number of 
patients [30]. 
In the field of gallstone management , a trial comparing lapa- 
roscopic cholecystectomy and the "mini-cholecystectomy" suf- 
fered from a high withdrawel rate after randomization, and this 
trial was eventually stopped because of ditficult patient recruit- 
ment [31]. The only alternative to overcome this particular 
problem clearly would have been to randomize patients without 
their informed consent, analogous to the European Carotid 
Surgery Trial [32]. 
Role of the Lay Press. The role of the lay press in hampering 
patient accrual has been recognized [29]. In our study the lay press 
played an important role in promoting patient preference. In 
some popular magazines the success of ESWL and of laparoscopic 
cholecystectomy were exaggerated, and the possibility of failure 
and complications were underestimated or not mentioned at all, 
which promoted the patient preference to a large extent. As a 
consequence, the universal adoption of laparoscopic cholecystec- 
tomy has been patient-driven [33, 34] as a result of media 
exposure [35]. 
Conclusions 
Our data confirm that proper information on the feasibility of a 
trial is not always available before the study is started [35]. Our 
data also confirm that it is not always feasible to conduct a 
randomized study because of inadequate patient accrual [9]. 
Furthermore, we confirmed that acquiring informed consent is 
much more difficult if treatment characteristics are divergent and 
that comparing different forms of therapy in a randomized study 
is hazardous in the quickly evolving field of surgery, such as the 
management of gallstone disease. It is therefore qually true that 
a prospective controlled study on the effects of laparoscopic 
cholecystectomy cannot be performed [7, 36]. In such cases 
alternatives to randomized studies must be used [8, 13, 26, 37]. 
R~sum~ 
Peu apr6s l'introduction de la lithotritie par ondes de choc 
extracorporelles (LOCE) comme modalit6 th6rapeutique nou- 
velle dans la lithiase biliaire, nous avons commenc6 une 6tude 
randomis6e pour 6valuer le cofits de la LOCE compar~e /t la 
choldcystectomie traditionnelle, le "gold standard". Pendant cette 
6tude s'dtalant sur une p6riode de trois ans, il n'a 6t6 possible, 
cependant, d'inclure que 8.3% seulement (37/488) des patients 
6ventuellement 61igibles. Trois facteurs pouvant emp~cher le 
recrutement ont pu 6tre identifi6s. Premibrement, un nombre 
limit6 de patients 61igibles pour la LOCE (et donc pour l'6tude), 
fait impr6visible selon les donndes de la litt6rature, deuxi6me- 
ment, 1'introduction de Ia chol6cystectomie par coelioscopie t 
son retentissement sur l'aspect h6rapeutique de la lithiase, et 
troisi6mement, la pr6f6rence du patient, refusant la randomisa- 
tion clans un bon nombre de cas. On conclue qu'il n'est pas 
toujours aussi facile de conduire une 6tude randomis6e n 
chirurgie, en raison des circonstances impr6vues. Entrer des 
patients dans un essai est tr6s difficile dans des domaines qui 
6voluent vite, tel que le traitement de la lithiase biliaire. Obtenir 
le consentement 6clair6 est 6galement difficile lorsque les mo- 
dalitds th6rapeutiques sont tr6s divergentes. I1 est probable que la 
rdalisation d'une 6tude randomis6e et contr616e sur les effets de la 
chol6cystectomie coelioscopique ne verra jamais le jour. 
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Resumen 
A1 poco tiempo de la introducci6n de la litotricia extracorp6rea 
(LEC) como un promisoria y novel modalidad terap6utica para la 
enfermedad litifisica biliar, se realiz6 un estudio randomizado 
para evaluar la efectividad en cuanto a costo en comparaci6n con 
la colecistectomfa abierta, que es el "patr6n oro". Se encontr6 que 
en los 3 afios del perfodo de ingreso de pacientes al estudio, s61o 
8.3% (36 = 7/448) de los pacientes pudieron ser ingresados, 
habi6ndose identificado tres que interfirieron con el recluta- 
miento. Primero, la restringida elegibilidad para LEC (y pot 
consiguiente para el estudio), lo cual no era predecible con base 
en la informaci6n de la literatura. Segundo, la introducci6n de la 
colecistectomfa l parosc6pica. Tercero, una fuerte preferencia 
por parte del paciente, lo cual inhibfa la randomizaci6n. Ninguno 
de estos mecanismos podfa ser previsto durante la fase de disefio 
del estudio. La conclusidn es que no siempre es factible conducir 
estudios randomizados en el campo de la cirug~a, debido a 
circunstancias imprevistas. Ingresar pacientes a ensayos cl[nicos 
en cirugfa es diffcil cuando se trata de campos de r~ipida evolu- 
ci6n, como lo es del manejo de la colelitiasis. Tambi6n es diffcil 
lograr el consentimiento informado cuando las caracterfsticas de 
las formas de tratamiento son muy divergentes. Es por ello, que 
posiblemente nunca se har~ un estudio randomizado sobre los 
efectos de la colecistectom[a laparosc6pica. 
Acknowledgments 
The Rotterdam Gallstone Study was supported by both the Dutch 
Ministry of Education and the Dutch National Health Insurance 
Council. 
References 
1. McSherry, C.K.: Cholecystectomy: the gold standard. Am. J. Surg. 
158:174, 1989 
2. Soper, N.J., Dunnegan, D.L.: Summary of NIH consensus develop- 
ment conference "gallstones and laparoscopic holecystectomy." 
World J. Surg. 17:21, 1993 
3. Vergunst, H., Terpstra, O.T., Brakel, K., Lam6ris, J.S., van Blanken- 
stein, M., Schr6der, F.H.: Extracorporeal shock wave lithotripsy of 
gallstones: possibilities and limitations. Ann. Surg. 210:565, 1989 
4. Sackmann, M., Delius, M., Sauerbruch, T., et al.: Shock-wave litho- 
tripsy of gallbladder stones: the first 175 patients. N. Engl. J. Med. 
318:393, 1988 
5. Burhenne, H.J.: The promise of extracorporeal shock-wave lithotripsy 
for the treatment of gallstones. Am. J. Roentgenol. 149:233, 1987 
6. Nijs, H.G.T., den Toom, R., Berger, M., Lubsen, J., Terpstra, O.T.: 
Extracorporeal shock wave lithotripsy versus cholecystectomy: the 
need for randomized clinical trials. J. Lithotripsy Stone Dis. 3:112, 
1991 
7. Neugebauer, E., Troidl, H., Spangenberger, W., Dietrich, A., kefer- 
ing, R., Cholecystectomy Study Group: Conventional versus laparo- 
scopic cholecystectomy and the randomized controlled trial. Br. J. 
Surg. 78:150, 1991 
8. Zelen, M.: A new design for randomized clinical trials. N. Engl. J. 
Med. 300:1242, 1979 
9. Van der Linden, W.: Pitfalls in randomized surgical trials. Surgery 
87:258, 1980 
10. Brewin, C.R., Bradley, C.: Patient preferences and randomised clini- 
cal trials. B.M.J. 299:313, 1989 
11. Pollock, A.V.: The rise and fall of the random controlled trial in 
surgery. Theor. Surg. 4:163, 1989 
12. Russell, P.S.: Commentary on "The rise and fall of the random 
controlled trial in surgery." Theor. Surg. 4:169, 1989 
13. Olschewski, M., Schumacher, M., Davis, K.B.: Analysis of randomized 
and nonrandomized patients in clinical trials using the comprehensive 
cohort follow-up study design. Controlled Clin. Trials 13:226, 1992 
14. Challah, S., Mays, N.B.: The randomised controlled trial in the 
evaluation of a new technology: a case study. B.M.J. 292:877, 1986 
15. Kahn, R.I.: Early United States experience with the EDAP LT-01 
piezoelectric shock wave Iithotripter. J. Lithotripsy Stone Dis. 1:224, 
1989 
16. Dudley, H.A.F.: Stones, lithotripters, trials and arguments. B.M.J. 
292:846, 1986 
17. Wiser, L.C., Plain, R.H., Dossetor, J.B.: Kidney stones and lithotript- 
ers: critical analysis of the introduction of extracorporeal shock wave 
lithotripsy into Canada. Can. Med. Assoc. J. 143:1299, 1990 
18. Paumgartner, G., Cart-Locke, D.L., Roda, E., Thistle, J.L.: Biliary 
stones: non-surgical therapeutic approach. Gastroenterol. Int. /:17, 
1988 
19. Maclntyre, I.M.C.: Tribulations for clinical trials: poor recruitment is 
hampering research. B.M.J. 302:1099, 1991 
20. Spodick, D.H.: Numerators without denominators: there is no FDA 
for the surgeon. J A.M.A. 232:35, 1975 
21. Milner, P.C., Nicholl, J., Westlake, L., et al.: The design of a 
randomized controlled trial for the evaluation of lithotripsy as a 
treatment for gallstones. J Lithotripsy Stone Dis. 1:122, 1989 
22. Southern Surgeons Club: A prospective analysis of 1518 laparoscopic 
cholecystectomies. N. Engl. J. Med. 324:3_073, 1991 
23. Cushieri, A, Dubois, F., Mouiel, J., et al.: The European experience 
with laparoscopic cholecystectomy. Am. J. Surg. 161:385, 1991 
24. Schirmer, B.D., Edge, S.B., Dix, J., Hyser, M.J., Hanks, J.B., Jones, 
R.S.: Laparoscopic cholecystectomy: treatment of choice for symp- 
tomatic holelithiasis. Ann. Surg. 213:665, 1991 
25. Oetinger, W., Beger, H.G.: Commentary on "The rise and fall of the 
random controlled trial in surgery." Theor. Surg. 4:170, 1989 
26. Angell, M.: Patient's preferences in clinical trials. N. Engl. J. Med. 
310:1385, 1984 
27. BARI, CABRI, EAST, GABI, AND RITA: Coronary angioplasty on 
trial [editorial]. Lancet 335:1315, 1990 
28. DeVita, V.T.: Breast cancer therapy: exercising all our options. N. 
Engl. J. Med. 320:527, 1989 
29. Jack, W.J.L., Cherty, U., Rodger, A.: Recruitment to a prospective 
breast conservation trial: why are so few patients randomised? B.M.J. 
30i:83, 1990 
30. Breeman, A., Serruys, P.W., van den Brand, M.J.B.M., et al.: Percu- 
tane transluminale coronaire angioplastiek versus coronaire chirurgie 
bij meervatslijden, een overzicht. Deel 2. Ned. Tijdschr. Cardiol. 
8:238, 1992 
31. Barkun, J.S., Barkun, A.N., Sampalis, J.S., et al.: Randomised con- 
trolled trial of laparoscopic versus mini cholecystectomy. Lancet 
340:1116, 1993 
32. European Carotid Surgery Trialists' Collaborative Group: MRC 
European Carotid Surgery Trial: interim results for symptomatic 
patients with severe (70-99%) or with mild (0-29%) carotid stenosis. 
Lancet 337:1235, 1991 
33. Emberton, M., Howerton, R.: Laparoscopic cholecystectomy [letter]. 
B.M.J. 304:777, 1992 
34. Miles, R.H., Carballo, R.E., Prinz, R.A., et al.: Laparoscopy: the 
preferred method of cholecystectomy in the morbidly obese. Surgery 
112:818, 1992 
35. Friedman, L.M., Furberg, C.D., DeMets, D.L.: Fundamentals of
Clinical Trials. PSG Publishing, Littleton, MA, 1985 
36. Carey, L.C.: Cholecystectomy--a new standard. Ann. Surg. 216:617, 
1992 
37. Hellman, S., Hellman, D.S.: Of mice but not men: problems of the 
randomized clinical trial. N. Engl. J. Med. 324:1585, 1991 
